| GO ID | Ontology | GO Term | Term Definition |
Proteins |
GO:0032269 | BP | negative regulation of cellular protein metabolic process | Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving a protein, occurring at the level of an individual cell. |
EDN1, MIF, NFKB1 |
GO:0032270 | BP | positive regulation of cellular protein metabolic process | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving a protein, occurring at the level of an individual cell. |
KLF4, AGT, TGFB1, INS, INHBA, AGTR1, AKT1, NR1H2, NR1H3, ADIPOQ, UHRF1 |
GO:0032272 | BP | negative regulation of protein polymerization | Any process that stops, prevents, or reduces the frequency, rate or extent of the process of creating protein polymers. |
VDAC2 |
GO:0032273 | BP | positive regulation of protein polymerization | Any process that activates or increases the frequency, rate or extent of the process of creating protein polymers. |
TPPP |
GO:0032275 | BP | luteinizing hormone secretion | The regulated release of luteinizing hormone, a gonadotropic glycoprotein hormone secreted by the anterior pituitary. |
TMF1 |
GO:0032279 | CC | asymmetric synapse | A type of synapse occurring between an axon and a dendritic spine or dendritic shaft. Asymmetric synapses, the most abundant synapse type in the central nervous system, involve axons that contain predominantly spherical vesicles and contain a thickened postsynaptic density. Most or all synapses of this type are excitatory. |
CHRM2, CHRM3, ADORA1, ARFGEF2 |
GO:0032280 | CC | symmetric synapse | A synapse that lacks an electron dense postsynaptic specialization. In vertebtrates, these occur primarily on dendrite shafts and neuronal cell bodies and involve persynapses containing clusters of predominantly flattened or elongated vesicles and are typcially inhibitory. |
PENK, CHRM2, ARFGEF2 |
GO:0032281 | CC | AMPA glutamate receptor complex | An assembly of four or five subunits which form a structure with an extracellular N-terminus and a large loop that together form the ligand binding domain. The C-terminus is intracellular. The ionotropic glutamate receptor complex itself acts as a ligand gated ion channel; on binding glutamate, charged ions pass through a channel in the center of the receptor complex. The AMPA receptors mediate fast synaptic transmission in the CNS and are composed of subunits GluR1-4, products from separate genes. These subunits have an extracellular N-terminus and an intracellular C-terminus. |
GRIA4, DLG4, SHISA6, ABHD12, CACNG8, ABHD6 |
GO:0032286 | BP | central nervous system myelin maintenance | The process in which the structure and material content of mature central nervous system myelin is kept in a functional state. |
CLU, PTEN, FA2H, MYRF |
GO:0032287 | BP | peripheral nervous system myelin maintenance | The process in which the structure and material content of mature peripheral nervous system myelin is kept in a functional state. |
AKT1, AKT2, FA2H, MPP5, SH3TC2, NDRG1 |
GO:0032288 | BP | myelin assembly | The process in which the wraps of cell membrane that constitute myelin are laid down around an axon in the central or peripheral nervous system. |
GPC1, ILK, MTMR2, MPP5, PIKFYVE |
GO:0032289 | BP | central nervous system myelin formation | The process in which the wraps of cell membrane that constitute myelin are laid down around an axon by an oligodendrocyte in the central nervous system. |
TLR2, ERCC2, TENM4 |
GO:0032290 | BP | peripheral nervous system myelin formation | The process in which the wraps of cell membrane that constitute myelin are laid down around an axon by an oligodendrocyte in the peripheral nervous system. |
DICER1 |
GO:0032298 | BP | positive regulation of DNA-dependent DNA replication initiation | Any process that activates or increases the frequency, rate or extent of initiation of DNA-dependent DNA replication. |
CDK2 |
GO:0032299 | CC | ribonuclease H2 complex | A protein complex that possesses ribonuclease H activity, in which the catalytic subunit is a member of the RNase H2 (or HII) class. For example, in Saccharomyces the complex contains Rnh201p, Rnh202p and Rnh203p. |
RNASEH2A, RNASEH2B |
GO:0032300 | CC | mismatch repair complex | Any complex formed of proteins that act in mismatch repair. |
MLH3 |
GO:0032301 | CC | MutSalpha complex | A heterodimer involved in the recognition and repair of base-base and small insertion/deletion mismatches. In human the complex consists of two subunits, MSH2 and MSH6. |
MSH2, MSH6 |
GO:0032302 | CC | MutSbeta complex | A heterodimer involved in binding to and correcting insertion/deletion mutations. In human the complex consists of two subunits, MSH2 and MSH3. |
MSH3, MSH2 |
GO:0032304 | BP | negative regulation of icosanoid secretion | Any process that stops, prevents, or reduces the frequency, rate or extent of the controlled release of an icosanoid from a cell. |
AGTR2 |
GO:0032308 | BP | positive regulation of prostaglandin secretion | Any process that activates or increases the frequency, rate or extent of the regulated release of a prostaglandin from a cell. |
IL1B, EDN1, MAP2K6, P2RX4 |
GO:0032310 | BP | prostaglandin secretion | The regulated release of a prostaglandin, any of a group of biologically active metabolites which contain a cyclopentane ring, from a cell or a tissue. |
ABCC4, LEP |
GO:0032311 | CC | angiogenin-PRI complex | A stable heterodimer of angiogenin and placental ribonuclease inhibitor; interaction between angiogenin and PRI prevents angiogenin binding to its receptor to stimulate angiogenesis. |
ANG, RNH1 |
GO:0032324 | BP | molybdopterin cofactor biosynthetic process | The chemical reactions and pathways resulting in the formation of the molybdopterin cofactor (Moco), essential for the catalytic activity of some enzymes, e.g. sulfite oxidase, xanthine dehydrogenase, and aldehyde oxidase. The cofactor consists of a mononuclear molybdenum (Mo-molybdopterin) or tungsten ion (W-molybdopterin) coordinated by one or two molybdopterin ligands. |
MOCOS, GPHN |
GO:0032330 | BP | regulation of chondrocyte differentiation | Any process that modulates the frequency, rate or extent of chondrocyte differentiation. |
SHOX2, MAF, CTGF, GLG1, LNP, TRPS1 |
GO:0032331 | BP | negative regulation of chondrocyte differentiation | Any process that stops, prevents, or reduces the frequency, rate or extent of chondrocyte differentiation. |
SNAI2, GREM1, GLI2, PTHLH, BMP4, CTNNB1, TGFBR1, GDF5, SOX9, ADAMTS12, EFEMP1, ADAMTS7 |
GO:0032332 | BP | positive regulation of chondrocyte differentiation | Any process that activates or increases the frequency, rate or extent of chondrocyte differentiation. |
FGF18, GLI3, BMP6, SOX6, GDF5, SOX9, SMAD3, RELA, ZBTB16, RUNX2, LOXL2 |
GO:0032342 | BP | aldosterone biosynthetic process | The chemical reactions and pathways resulting in the formation of aldosterone, a corticosteroid hormone that is produced by the zona glomerulosa of the adrenal cortex and regulates salt (sodium and potassium) and water balance. |
CYP11B1, CYP11B2 |
GO:0032348 | BP | negative regulation of aldosterone biosynthetic process | Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of aldosterone. |
BMP2, DKK3 |
GO:0032349 | BP | positive regulation of aldosterone biosynthetic process | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of aldosterone. |
BMP6 |
GO:0032350 | BP | regulation of hormone metabolic process | Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving any hormone. |
TCF7L2 |
GO:0032354 | BP | response to follicle-stimulating hormone | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a follicle-stimulating hormone stimulus. |
ASNS, SRD5A1, SRD5A2, TGFBR3, PAPPA |
GO:0032355 | BP | response to estradiol | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen. |
SOCS2, DHH, ALDH1A2, MBD4, MBD3, ASS1, CST3, TGFB1, PENK, GH1, CD4, COL1A1, CRYAB, ESR1, ANXA1, GPI, TH, GSTP1, PDGFRB, TFPI, ESRRA, PCNA, EEF2, ETS1, AREG, NQO1, IGFBP2, PAM, NR2F2, CALR, DUSP1, CTGF, SLC6A1, OXTR, CTNNB1, PTGS2, STAT3, OPRL1, LEP, ADCYAP1R1, PTGFR, CDKN1B, MMP15, STAT5B, CASP9, BID, PTEN, STRN3, PTCH1, KCNJ11, CASP8, POSTN, NCOA1, EZH2, BAD, TXNIP, WFDC1, DNMT3B |
GO:0032357 | MF | oxidized purine DNA binding | Interacting selectively and non-covalently with oxidized purine residues in DNA. |
MSH2, MSH6 |
GO:0032364 | BP | oxygen homeostasis | A homeostatic process involved in the maintenance of an internal steady state of oxygen within an organism or cell. |
SOD2, HIF1A |
GO:0032366 | BP | intracellular sterol transport | The directed movement of sterols within cells. |
NPC2 |
GO:0032367 | BP | intracellular cholesterol transport | The directed movement of cholesterol, cholest-5-en-3-beta-ol, within cells. |
ABCA1, STAR, NPC2, STARD4 |
GO:0032368 | BP | regulation of lipid transport | Any process that modulates the frequency, rate or extent of the directed movement of lipids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
PARK2 |
GO:0032369 | BP | negative regulation of lipid transport | Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of lipids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
ITGB3, ITGAV, NR1H2, NR1H3 |
GO:0032374 | BP | regulation of cholesterol transport | Any process that modulates the frequency, rate or extent of the directed movement of cholesterol into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
APOC1, TSPO |
GO:0032375 | BP | negative regulation of cholesterol transport | Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of cholesterol into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
APOA2, APOC1, NFKB1 |
GO:0032376 | BP | positive regulation of cholesterol transport | Any process that activates or increases the frequency, rate or extent of the directed movement of cholesterol into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
NR1H2, NR1H3, LIPG |
GO:0032385 | BP | positive regulation of intracellular cholesterol transport | Any process that activates or increases the frequency, rate or extent of the directed movement of cholesterol within cells. |
SCP2 |
GO:0032386 | BP | regulation of intracellular transport | Any process that modulates the frequency, rate or extent of the directed movement of substances within cells. |
WWC1 |
GO:0032387 | BP | negative regulation of intracellular transport | Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of substances within cells. |
CRYAB, MAPT, MAP1B |
GO:0032388 | BP | positive regulation of intracellular transport | Any process that activates or increases the frequency, rate or extent of the directed movement of substances within cells. |
CAPN10 |
GO:0032389 | CC | MutLalpha complex | A heterodimer involved in the recognition of base-base and small insertion/deletion mismatches. In human the complex consists of two subunits, MLH1 and PMS2. |
MLH1, PMS1 |
GO:0032391 | CC | photoreceptor connecting cilium | A nonmotile primary cilium that has a 9+0 microtubule array and forms the portion of the axoneme traversing the boundary between the photoreceptor inner and outer segments. |
NPHP1, C21orf2, MAK, SEPT2, FAM161A, KIFAP3, IFT122, SPATA7 |
GO:0032392 | BP | DNA geometric change | The process in which a transformation is induced in the geometry of a DNA double helix, resulting in a change in twist, writhe, or both, but with no change in linking number. Includes the unwinding of double-stranded DNA by helicases. |
HMGB3, HMGB1, HMGB2, MTERF1 |
GO:0032393 | MF | MHC class I receptor activity | Combining with an MHC class I protein complex to initiate a change in cellular activity. Class I here refers to classical class I molecules. |
LILRB1, MR1 |
GO:0032395 | MF | MHC class II receptor activity | Combining with an MHC class II protein complex and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. |
HLA-DRA, HLA-DQA2, HLA-DQA1, HLA-DQB1, HLA-DOB, HLA-DPA1, HLA-DRB3, KRT17 |
GO:0032398 | CC | MHC class Ib protein complex | A transmembrane protein complex composed of a MHC class Ib alpha chain and, in most cases, an invariant beta2-microglobin chain, and with or without a bound peptide or lipid antigen. Class Ib here refers to non-classical class I molecules, such as those of the CD1 or HLA-E gene families. |
HLA-E |
GO:0032400 | BP | melanosome localization | Any process in which a melanosome is transported to, and/or maintained in, a specific location within the cell. |
RAB27A |
GO:0032401 | BP | establishment of melanosome localization | The directed movement of a melanosome to a specific location. |
SHROOM2 |
GO:0032402 | BP | melanosome transport | The directed movement of melanosomes into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
RAB27B, RAB27A, RAB11A, RAB1A, DCTN2, DCTN1, RAB11B, BLOC1S3, BBS7, BBS2, MKKS, BLOC1S6, MYO5A |
GO:0032403 | MF | protein complex binding | Interacting selectively and non-covalently with any protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
APBB1, NDUFA4, KRIT1, ITGB1BP1, FYB, CFLAR, ULK1, TULP3, CRTAP, MYC, NRAS, KRAS, NR3C1, ITGB2, ITGB1, KRT8, C8G, TUBB, KRT19, RRAS, PTPRF, HSPD1, THRA, CDK4, HCLS1, EPCAM, ITGA2, ATF1, UQCRC2, FBLN1, PPIB, NFYB, UQCRC1, YWHAB, FBN1, PPP1CC, SREBF1, CDKN1A, CAPG, MTHFR, NSF, CDKN1B, IQGAP1, UQCRFS1, TMED10, RANBP2, BCAP31, KIF11, IST1, EPHB1, ATP6V0D1, PPP1CA, RAP1A, GNB1, RBX1, GNB2, AP2B1, IGBP1, DLG4, SLC25A3, SPTBN1, RELA, KHDRBS1, PPARA, TWF1, STRN3, FADD, PDCL, MAPK8IP2, RIPK1, CUL2, PTCH1, DAG1, GIT2, COG2, CASP8, TCEB1, NR0B2, TRADD, TSN, TAB1, NCOA1, LRRC16A, CYFIP1, SLF2, ABI1, FLCN, KAT6B, KAT2B, UFD1L, TXN2, SLF1, TAPBPL, NDEL1, STRN4, RAD18, ABI2, PLK2, CRIPT, GIT1, WASF2 |
GO:0032405 | MF | MutLalpha complex binding | Interacting selectively and non-covalently with the mismatch repair complex MutLalpha. |
PCNA, MSH2, MSH6 |
GO:0032407 | MF | MutSalpha complex binding | Interacting selectively and non-covalently with the mismatch repair complex MutSalpha. |
MLH1, MUTYH |
GO:0032410 | BP | negative regulation of transporter activity | Any process that stops or reduces the activity of a transporter. |
WWP2, SNCA, NDFIP1, NDFIP2, CTTNBP2NL |
GO:0032411 | BP | positive regulation of transporter activity | Any process that activates or increases the activity of a transporter. |
SYNGR3, PON1, SGK3 |
GO:0032412 | BP | regulation of ion transmembrane transporter activity | Any process that modulates the activity of an ion transporter. |
AHCYL1 |
GO:0032414 | BP | positive regulation of ion transmembrane transporter activity | Any process that activates or increases the activity of an ion transporter. |
WNK3, WNK1, TRPC6 |
GO:0032417 | BP | positive regulation of sodium:proton antiporter activity | Any process that activates or increases the activity of a sodium:hydrogen antiporter, which catalyzes the reaction: Na+(out) + H+(in) = Na+(in) + H+(out). |
ACTN4, CHP1 |
GO:0032418 | BP | lysosome localization | Any process in which a lysosome is transported to, and/or maintained in, a specific location. |
SNAPIN, BLOC1S1, LAMTOR1, LOH12CR1, BORCS6, RAB34, TMEM106B, ARL8B, HDAC6 |
GO:0032419 | CC | extrinsic component of lysosome membrane | The component of an lysosome membrane consisting of gene products and protein complexes that are loosely bound to one of its surfaces, but not integrated into the hydrophobic region. |
RAB7A |
GO:0032420 | CC | stereocilium | An actin-based protrusion from the apical surface of auditory and vestibular hair cells and of neuromast cells. These protrusions are supported by a bundle of cross-linked actin filaments (an actin cable), oriented such that the plus (barbed) ends are at the tip of the protrusion, capped by a tip complex which bridges to the plasma. Bundles of stereocilia act as mechanosensory organelles. |
ATP8B1, RDX, MPP1, EPS8, TWF2, GPR98, BBS2, CLIC5 |
GO:0032422 | MF | purine-rich negative regulatory element binding | Interacting selectively and non-covalently with a 30-bp purine-rich negative regulatory element; the best characterized such element is found in the first intronic region of the rat cardiac alpha-myosin heavy chain gene, and contains two palindromic high-affinity Ets-binding sites (CTTCCCTGGAAG). The presence of this element restricts expression of the gene containing it to cardiac myocytes. |
ELK3, PURA |
GO:0032425 | BP | positive regulation of mismatch repair | Any process that activates or increases the frequency, rate or extent of mismatch repair. |
HMGB1 |
GO:0032427 | MF | GBD domain binding | Interacting selectively and non-covalently with the GTPase protein binding domain (GDB) domain of a protein. The GBD is a short motif, including a minimum region of 16 amino acids, identified in proteins that bind to small GTPases such as Cdc42 and Rac. |
RHOQ |
GO:0032428 | MF | beta-N-acetylgalactosaminidase activity | Catalysis of the hydrolysis of terminal non-reducing N-acetyl-D-galactosamine residues in N-acetyl-beta-D-galactosaminides. |
GM2A |
GO:0032429 | BP | regulation of phospholipase A2 activity | Any process that modulates the activity of the enzyme phospholipase A2. |
PPT1 |
GO:0032430 | BP | positive regulation of phospholipase A2 activity | Any process that activates or increases the activity of the enzyme phospholipase A2. |
AGTR1 |
GO:0032431 | BP | activation of phospholipase A2 activity | Any process that initiates the activity of the inactive enzyme phospholipase A2. |
ANG |
GO:0032432 | CC | actin filament bundle | An assembly of actin filaments that are on the same axis but may be oriented with the same or opposite polarities and may be packed with different levels of tightness. |
CRYAB, LCP1, PLS1, FAM101A, FAM101B |
GO:0032433 | CC | filopodium tip | The end of a filopodium distal to the body of the cell. |
EPHB1, FMR1, NLGN1, CIB1, TTYH1, MYO10, MYO5A |
GO:0032434 | BP | regulation of proteasomal ubiquitin-dependent protein catabolic process | Any process that modulates the frequency, rate or extent of the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome. |
RAD23A, RAD23B, GNA12, COMMD1, GLMN, DDA1, UBQLN4 |
GO:0032435 | BP | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | Any process that stops, prevents, or reduces the frequency, rate or extent of the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome. |
SDCBP, N4BP1, HSP90AB1, FHIT, MTM1, HFE, CCAR2, SMARCC1, PBK, WAC, BAG5 |
GO:0032436 | BP | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | Any process that activates or increases the frequency, rate or extent of the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome. |
AURKA, SMAD7, PARK2, SOCS5, PSMD10, IL33, CLU, AKT1, GCLC, CSNK1A1, CSNK1D, CSNK1E, PSEN1, GSK3B, RNF144A, PLK1, VCP, SUMO2, RACK1, DAB2, MDM2, UBE2V2, RNF19B, RNF144B, BBS7, SIRT2, FBXO22, TRIB2, PRICKLE1, TRIB3, TRIB1, RNF19A, PLK2, RNF14, STUB1, ARIH1, RNF114, NUB1 |
GO:0032437 | CC | cuticular plate | A dense network of actin filaments found beneath the apical cell surface of hair cells, and into which stereocilia are inserted. |
SPTBN1 |
GO:0032438 | BP | melanosome organization | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a melanosome. A melanosome is a tissue-specific, membrane-bounded cytoplasmic organelle within which melanin pigments are synthesized and stored. |
AP3D1, RAB29, SNAPIN, PMEL, BLOC1S1, SHROOM2, BLOC1S3, LYST, BLOC1S6 |
GO:0032439 | BP | endosome localization | Any process in which endosomes are transported to, and/or maintained in, a specific location within the cell. |
LAMTOR1, ANKFY1, MYO5B |
GO:0032440 | MF | 2-alkenal reductase [NAD(P)] activity | Catalysis of the reaction: n-alkanal + NAD(P)+ = alk-2-enal + NAD(P)H + H+. |
PTGR1 |
GO:0032444 | CC | activin responsive factor complex | A transcriptionally active complex that binds to an activin response element (ARE) in the promoter of target genes, and is composed of two SMAD2 proteins, one SMAD4 protein and a Forkhead activin signal transducer (FAST) transcription factor. |
SMAD4, SMAD2 |
GO:0032446 | BP | protein modification by small protein conjugation | A protein modification process in which one or more groups of a small protein, such as ubiquitin or a ubiquitin-like protein, are covalently attached to a target protein. |
UBD, ATG10 |
GO:0032448 | MF | DNA hairpin binding | Interacting selectively and non-covalently with DNA containing a hairpin. A hairpin structure forms when a DNA strand folds back on itself and intrachain base pairing occurs between inverted repeat sequences. |
NR0B1 |
GO:0032449 | CC | CBM complex | A protein complex comprising Carma1, Bcl10 and MALT1; plays a role in signal transduction during NF-kappaB activation. |
BCL10, CARD10 |
GO:0032450 | MF | maltose alpha-glucosidase activity | Catalysis of the reaction: alpha-maltose + H2O = 2 alpha-D-glucose. |
MGAM, GAA |
GO:0032451 | MF | demethylase activity | Catalysis of the removal of a methyl group from a substrate. |
KDM1A, CYP1A1 |
GO:0032452 | MF | histone demethylase activity | Catalysis of the removal of a methyl group from a histone. |
UTY, KDM6A, KDM1A, KDM4B, KDM5A, ARID5B, JMJD6, KDM7A, KDM5B, KDM2A |
GO:0032453 | MF | histone demethylase activity (H3-K4 specific) | Catalysis of the removal of a methyl group from lysine at position 4 of the histone H3 protein. |
KDM1A, KDM5B |
GO:0032454 | MF | histone demethylase activity (H3-K9 specific) | Catalysis of the reaction: histone H3 N6-methyl-L-lysine (position 9) + alpha-ketoglutarate + O2 = succinate + CO2 + formaldehyde + lysine. This reaction is the removal of a methyl group from lysine at position 9 of the histone H3 protein. |
KDM1A, JMJD1C, KDM7A |
GO:0032455 | BP | nerve growth factor processing | The generation of a mature nerve growth factor (NGF) by proteolysis of a precursor. |
NGF, FURIN, PCSK6, PCSK5 |
GO:0032456 | BP | endocytic recycling | The directed movement of membrane-bounded vesicles from recycling endosomes back to the plasma membrane where they are recycled for further rounds of transport. |
STX6, RAB11FIP3, SNX4, EPS15, VPS52, DENND1A, EHD4, EPG5, EHD3 |
GO:0032460 | BP | negative regulation of protein oligomerization | Any process that stops, prevents, or reduces the frequency, rate or extent of protein oligomerization. |
INS, SORL1 |
GO:0032461 | BP | positive regulation of protein oligomerization | Any process that activates or increases the frequency, rate or extent of protein oligomerization. |
MMP1, TP53, CCK, IDE, BID, BAX, PMAIP1, TRABD2A, SH3GLB1, SNX9 |
GO:0032463 | BP | negative regulation of protein homooligomerization | Any process that stops, prevents, or reduces the frequency, rate or extent of protein homooligomerization. |
CLU |
GO:0032464 | BP | positive regulation of protein homooligomerization | Any process that activates or increases the frequency, rate or extent of protein homooligomerization. |
BCL2L11, FAS, BID, RACK1, MIEF2 |
GO:0032465 | BP | regulation of cytokinesis | Any process that modulates the frequency, rate or extent of the division of the cytoplasm of a cell and its separation into two daughter cells. |
AURKA, PRPF40A, BRCA2, CALM2, PIK3C3, FLCN, PIK3R4, GIT1, SH3GLB1 |
GO:0032466 | BP | negative regulation of cytokinesis | Any process that stops, prevents, or reduces the frequency, rate or extent of the division of the cytoplasm of a cell, and its separation into two daughter cells. |
E2F8, TEX14, AURKB, ZFYVE19 |
GO:0032467 | BP | positive regulation of cytokinesis | Any process that activates or increases the frequency, rate or extent of the division of the cytoplasm of a cell, and its separation into two daughter cells. |
DRD2, CDC25B, SSTR5, CDC42, RHOA, KIF23, CUL3, KIF14, PKN2, CSPP1, CENPV, AURKB, KIF20B, PKP4, CDC6, RACGAP1, ECT2, SPAST |
GO:0032468 | BP | Golgi calcium ion homeostasis | Any process involved in the maintenance of an internal steady state of calcium ions within the Golgi apparatus of a cell or between the Golgi and its surroundings. |
ATP2C1 |